Professor Chris Mason MBBS PhD FSB FRCSI FRCS
Cell Therapy + Regenerative Medicine Bioprocessing Unit
Advanced Centre for Biochemical Engineering
University College London
GMC Registration Number: 4121734
Chris holds a Clinical Sciences degree from Imperial College London, a Medical degree from the United Medical & Dental Schools of Guy’s & St. Thomas’s Hospitals (now King’s College London) & a PhD under the supervision of Prof. Peter Dunnill in tissue-engineering bioprocessing from University College London.
Following graduation, Chris specialized in surgery & is a Fellow of the Royal College of Surgeons both of England & in Ireland. Today, after a transition from clinical practice to translational research, he holds a Personal Chair in Regenerative Medicine Bioprocessing in the UCL Advanced Centre for Biochemical Engineering & is on the Steering Committee for the UCL Centre for Stem Cells & Regenerative Medicine. Other responsibilities include; being Senior Editor of "Regenerative Medicine" journal, Trustee of the UK Stem Cell Foundation (UKSCF) & the British Neurological Research Trust, co-founder & Director of the London Regenerative Medicine Network (LRMN) - the world’s first & largest regenerative medicine network, member of the UK-Israel Life Sciences Council, member of the Clinical Trials, Biologicals & Vaccines Expert Advisory Group of the Commission on Human Medicines, & member of the United States Pharmacopeia (USP) Monographs - Biologics & Biotechnology Expert Committee.
Chris is on a number of national & international committees, working groups & initiatives related to the academic, clinical & commercial advancement of cell-based therapies & tissue engineering including; Chair of the BIA Cell Therapy & Regenerative Medicine Industry Group & member of the ISSCR Industry Committee, the Alliance for Regenerative Medicine (ARM) Communication & Education Committee & ISCT Commercialization Committee. In May 2012, he became the first President of The Regenerative Medicine Coalition. He is on the Strategic Advisory Board of the Canadian Centre for the Commercialisation of Regenerative Medicine (CCRM) & Advisory Boards of a number of companies based in North America. On many occasions Chris has acted as a general spokesperson for the sector including newspaper, radio, TV & webinar interviews plus frequent news briefings. The Cell Therapy Industry Index (CTI), published biannually in Cell Stem Cell is produced by Chris & his collaborators at the Harvard Stem Cell Institute, LRMN & Proteus Regenerative Medicine.
Having won several awards, Chris was particularly delighted to have had the opportunity in 2007 to give a Royal Institution of Great Britain, Friday Evening Discourse - "Therapeutic potential of human stem cells: promise & pitfalls" & again in 2013 - “The race to be a Cell Therapy Nation”. Chris also participated in the 2013 Vatican Stem Cell Conference & expressed his firmly held view that all cell types potentially have a role to play in therapy.
Chris lives on the beautiful south coast of England & is happily married to Dr. Louise Mason. Louise is a Consultant Physician in Palliative Medicine at a leading UK teaching hospital & a Fellow of the Royal College of Physicians.